← Back to search

National Institutes of Health · Department of Health and Human Services

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Open · Opportunity PAR-25-226 · Assistance Listing 93.242

Key facts

Deadline
Due Nov 19, 2026 · 44 days left
Award size
Not specified — see notice
Cost share / match ?
Not required
Who can apply
School district, Other (see eligibility), Nonprofit without 501(c)(3), Tribal government, Private college or university, County government, Tribal organization, Special district (utility, fire, etc.), Nonprofit with 501(c)(3), Larger business, City or town government, Small business, State government, Public college or university
Where
Anywhere in the U.S., including Tennessee

Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. Registration is free but can take weeks, so start now, not when the deadline is close. Grant-ready checklist

How this fits you

  • Available in Tennessee (nationwide program)
  • No cost share required
  • Tennessee recipients since 2023: 22

Tell us who you are to see whether you're eligible.

More from National Institutes of Health

Read the official notice View on Grants.gov Add deadline to my calendar Sign in to save

About this grant

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD). Candidate interventions evaluated through this program, which can include small molecules or biologics for example, must engage non-amyloid/non-tau mechanisms and aim to address cognitive and/or neuropsychiatric symptoms in individuals across the spectrum from pre-symptomatic to more severe stages of disease. This NOFO uses the UG3/UH3 phased award mechanism and proposals must include prespecified, go/no-go safety and tolerability milestones that gate the advance from phase 1 to latter stages of clinical development.

Eligibility (from the notice)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Who in Tennessee has won this program

22 awards to Tennessee recipients in 2 counties since federal FY2023. Largest shown:

Past Tennessee recipients
RecipientWhereAmountFY
Vanderbilt UniversityNashville, Davidson County$8.7M2001
Vanderbilt UniversityNashville, Davidson County$8.7M2006
Vanderbilt UniversityNashville, Davidson County$8.1M2005
Vanderbilt University Medical CenterNashville, Davidson County$7.4M2020
Vanderbilt UniversityNashville, Davidson County$6.8M2004
Vanderbilt University Medical CenterNashville, Davidson County$6.4M2005
Vanderbilt UniversityNashville, Davidson County$5.4M2009
Vanderbilt University Medical CenterNashville, Davidson County$5.3M2020
Vanderbilt UniversityNashville, Davidson County$5M2002
Vanderbilt UniversityNashville, Davidson County$4.5M1989
Vanderbilt University Medical CenterNashville, Davidson County$4.3M2019
Vanderbilt University Medical CenterNashville, Davidson County$4.1M2014

Source: USAspending.gov. Past awards show who this program funds; they don't guarantee future awards.

About the program (93.242)

Mental Health Research Grants

How applications are judged

The following consideration will be used in determining projects to be funded: (1) Technical merit of the proposed project as determined by peer review; (2) Availability of funds; and (3) Relevance to program priorities.

Matching requirements

This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.

Examples of funded projects

Not Applicable.

Program listing on SAM.gov

Something wrong with this listing? Tell us
What's wrong?